DOI: https://doi.org/10.36347/sasjm.2026.v12i01.007

Pages: 47-52

With more than 3,300 new cases and nearly 2,500 deaths each year, cervical cancer (CC) ranks second among female cancers in Moroccan women in terms of incidence and mortality. Our study aimed to describe the epidemiological, clinical and histopathological characteristics of patients with cervical cancer treated in the gynecology II department of the CHU HASSAN II de Fès.100 patients were included in our series: the most represented age group is that of 48-56 years old; 80% were married, 54% came from the city of Fez; no toxic habits have been found. The age of first reports was revealed in 10 patients with extremes between 18-25 years. Metrorrhagia (67%) constituted the main reason for consultation followed by leucorrhea in 23% and urinary signs in 10%. No cases of cervical cancer were diagnosed at stage 0 (in situ). Only 15% were diagnosed at stage I. Most patients, 76%, came to the hospital at stages II and 9% at stage III. Regarding the histological type, it is mainly represented by squamous cell carcinoma (87%), followed by adenocarcinoma in 9% and squamous cell carcinoma in 2%. The thoraco-obadomino-pelvic scanner was the standard given its accessibility; Stage IIB accounted for 35%, followed by stage IIIC1 in 23% of our series, the metastatic sites were essentially bone and lung. On the treatment side, only 3 of our patients benefited from a primary surgery consisting of an expanded total hysterectomy, rcc+ brachytherapy was administered to 86 patients, radiotherapy was exclusive in one patient and palliative chemotherapy was administered in 9 patients.12% of deaths are found and 13% of progression in our series.